Subscribe
istock-846581142-lpettet-1
lpettet / iStockphoto.com
10 June 2021Plant VarietiesAlex Baldwin

Brands urged to ‘cast a wide net’ for cannabis TMs: WIPR TM Live

Companies looking to enter the booming cannabis industry should “cast a wider net” when registering trademarks, according to a virtual panel discussion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Exhaustion and parallel trade: what’s next for pharma TMs?
1 December 2022   As the ‘UK+’ exhaustion regime is set to continue for now, Rebecca Anderson-Smith of Mewburn Ellis explores how pharma firms should protect their rights.
Plant Varieties
Cannabis firm asks court to consider new evidence in TM suit
15 June 2021   A cannabis company has asked a district court to reconsider its summary judgment motion in a lawsuit over the trademark ‘Kiva’ in light of new evidence.
Plant Varieties
Sacha Baron Cohen sues cannabis company for copyright infringement
13 July 2021   Actor and comedian Sacha Baron Cohen is suing a US medical cannabis company for its use of his controversial Borat character on a billboard advertisement without his authorisation.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Exhaustion and parallel trade: what’s next for pharma TMs?
1 December 2022   As the ‘UK+’ exhaustion regime is set to continue for now, Rebecca Anderson-Smith of Mewburn Ellis explores how pharma firms should protect their rights.
Plant Varieties
Cannabis firm asks court to consider new evidence in TM suit
15 June 2021   A cannabis company has asked a district court to reconsider its summary judgment motion in a lawsuit over the trademark ‘Kiva’ in light of new evidence.
Plant Varieties
Sacha Baron Cohen sues cannabis company for copyright infringement
13 July 2021   Actor and comedian Sacha Baron Cohen is suing a US medical cannabis company for its use of his controversial Borat character on a billboard advertisement without his authorisation.

More on this story

Big Pharma
Exhaustion and parallel trade: what’s next for pharma TMs?
1 December 2022   As the ‘UK+’ exhaustion regime is set to continue for now, Rebecca Anderson-Smith of Mewburn Ellis explores how pharma firms should protect their rights.
Plant Varieties
Cannabis firm asks court to consider new evidence in TM suit
15 June 2021   A cannabis company has asked a district court to reconsider its summary judgment motion in a lawsuit over the trademark ‘Kiva’ in light of new evidence.
Plant Varieties
Sacha Baron Cohen sues cannabis company for copyright infringement
13 July 2021   Actor and comedian Sacha Baron Cohen is suing a US medical cannabis company for its use of his controversial Borat character on a billboard advertisement without his authorisation.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?